Mikaone 500 Injection
Marketer
Conch Healthcare Pvt Ltd
Salt Composition
Amikacin (500mg)
Overview Mikaone 500 Injection
Cefamika 500 Injection, an antibiotic medication, combats a broad spectrum of bacterial infections. These can affect various body systems, including the urinary tract, skeletal system (bones and joints), respiratory system (such as pneumonia), central nervous system, and circulatory system. Prophylactic use in hospitalized patients is also indicated. Cefamika 500 Injection's mechanism involves bacterial growth inhibition. Administered intravenously (drip) or intramuscularly by a healthcare provider, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; consistent, evenly spaced doses are essential. Completing the entire course is vital, even with symptom improvement; premature cessation risks relapse or infection exacerbation. Common adverse reactions include injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High-dose therapy may induce vertigo, nephrotoxicity (kidney damage), and ototoxicity (hearing impairment). Strict adherence to physician instructions is paramount, potentially including regular kidney function, hearing, and urine assessments. This medication is contraindicated during pregnancy. Disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Mikaone 500 Injection
Infections caused by bacteria
Major Benefits of Mikaone 500 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Mikaone 500 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikaone 500 Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
How Mikaone 500 Injection works:
Mikaone 500 Injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Mikaone 500 Injection may be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikaone 500 Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary when the potential advantages outweigh the known hazards. Seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Administration of Mikaone 500 Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal transfer of the medication into breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Administration of Mikaone 500 Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administration of Mikaone 500 Injection requires careful consideration. Dosage modification of Mikaone 500 Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Mikaone 500 Injection in patients with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Mikaone 500 Injection :
Omitting a scheduled Mikaone 500 Injection requires immediate physician consultation.
Facts to Know About Mikaone 500 Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently